Vericel (VCEL) Gross Profit Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.47% |
| Dec 31, 2025 | 16.80% |
| Sep 30, 2025 | 17.15% |
| Jun 30, 2025 | 32.64% |
| Mar 31, 2025 | 16.70% |
| Dec 31, 2024 | 15.22% |
| Sep 30, 2024 | 14.49% |
| Jun 30, 2024 | 16.40% |
| Mar 31, 2024 | 21.83% |
| Dec 31, 2023 | 16.39% |
| Sep 30, 2023 | 16.36% |
| Jun 30, 2023 | 21.55% |
| Mar 31, 2023 | 20.68% |
| Dec 31, 2022 | 20.65% |
| Sep 30, 2022 | 28.96% |
| Jun 30, 2022 | 19.74% |
| Mar 31, 2022 | 59.78% |
| Dec 31, 2021 | 17.87% |
| Sep 30, 2021 | 40.25% |
| Jun 30, 2021 | 37.26% |
| Mar 31, 2021 | 24.95% |
| Dec 31, 2020 | 32.65% |
| Sep 30, 2020 | 37.71% |
| Jun 30, 2020 | 11.16% |
| Mar 31, 2020 | 25.98% |
| Dec 31, 2019 | 29.35% |
| Sep 30, 2019 | 38.69% |
| Jun 30, 2019 | 99.61% |
| Dec 31, 2018 | 403.74% |
| Jun 30, 2018 | 462.71% |
| Mar 31, 2018 | 344.07% |
| Dec 31, 2017 | 297.90% |
| Sep 30, 2016 | 257.24% |
| Mar 31, 2016 | 304.15% |